These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 11274278

  • 1. Prostaglandin inhibition by intraperitoneal indomethacin has no effect on peritoneal permeability during stable CAPD.
    Douma CE, de Waart DR, Zemel D, Struijk DG, Krediet RT.
    Nephrol Dial Transplant; 2001 Apr; 16(4):803-8. PubMed ID: 11274278
    [Abstract] [Full Text] [Related]

  • 2. Effect of amino acid based dialysate on peritoneal blood flow and permeability in stable CAPD patients: a potential role for nitric oxide?
    Douma CE, de Waart DR, Struijk DG, Krediet RT.
    Clin Nephrol; 1996 May; 45(5):295-302. PubMed ID: 8738660
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Icodextrin with nitroprusside increases ultrafiltration and peritoneal transport during long CAPD dwells.
    Douma CE, Hiralall JK, de Waart DR, Struijk DG, Krediet RT.
    Kidney Int; 1998 Apr; 53(4):1014-21. PubMed ID: 9551412
    [Abstract] [Full Text] [Related]

  • 6. Effects of intraperitoneal cyclooxygenase inhibition on inflammatory mediators in dialysate and peritoneal membrane characteristics during peritonitis in continuous ambulatory peritoneal dialysis.
    Zemel D, Struijk DG, Dinkla C, Stolk LM, ten Berge IJ, Krediet RT.
    J Lab Clin Med; 1995 Aug; 126(2):204-15. PubMed ID: 7636393
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prostaglandin-mediated loss of proteins during peritonitis in continuous ambulatory peritoneal dialysis.
    Steinhauer HB, Schollmeyer P.
    Kidney Int; 1986 Feb; 29(2):584-90. PubMed ID: 3457982
    [Abstract] [Full Text] [Related]

  • 11. Peritoneal transport characteristics with glucose polymer based dialysate.
    Ho-dac-Pannekeet MM, Schouten N, Langendijk MJ, Hiralall JK, de Waart DR, Struijk DG, Krediet RT.
    Kidney Int; 1996 Sep; 50(3):979-86. PubMed ID: 8872974
    [Abstract] [Full Text] [Related]

  • 12. Analysis of inflammatory mediators and peritoneal permeability to macromolecules shortly before the onset of overt peritonitis in patients treated with CAPD.
    Zemel D, Betjes MG, Dinkla C, Struijk DG, Krediet RT.
    Perit Dial Int; 1995 Sep; 15(2):134-41. PubMed ID: 7612733
    [Abstract] [Full Text] [Related]

  • 13. Contribution of lymphatic absorption to loss of ultrafiltration and solute clearances in continuous ambulatory peritoneal dialysis.
    Mactier RA, Khanna R, Twardowski Z, Moore H, Nolph KD.
    J Clin Invest; 1987 Nov; 80(5):1311-6. PubMed ID: 3680499
    [Abstract] [Full Text] [Related]

  • 14. Changes in water transport across the peritoneum during treatment with continuous ambulatory peritoneal dialysis in selected patients with and without peritonitis.
    Radtke M, Albrektsen GE, Widerøe TE, Nilsen TI, Romundstad P, Hallan S, Aasarød K, Laegreid IK, Oien C.
    Perit Dial Int; 2004 Nov; 24(6):571-9. PubMed ID: 15559487
    [Abstract] [Full Text] [Related]

  • 15. Peritoneal fluid transport in CAPD patients with different transport rates of small solutes.
    Sobiecka D, Waniewski J, Weryński A, Lindholm B.
    Perit Dial Int; 2004 Nov; 24(3):240-51. PubMed ID: 15185772
    [Abstract] [Full Text] [Related]

  • 16. Coagulation- and fibrinolysis-related antigens in plasma and dialysate of CAPD patients.
    Goedde M, Sitter T, Schiffl H, Bechtel U, Schramm W, Spannagl M.
    Perit Dial Int; 1997 Nov; 17(2):162-6. PubMed ID: 9159837
    [Abstract] [Full Text] [Related]

  • 17. Can the inflammation markers of patients with high peritoneal permeability on continuous ambulatory peritoneal dialysis be reduced on nocturnal intermittent peritoneal dialysis?
    Cueto-Manzano AM, Rojas-Campos E, Martínez-Ramírez HR, Valera-González I, Medina M, Monteón F, Ruiz N, Becerra M, Palomeque MA, Cortés-Sanabria L.
    Perit Dial Int; 2006 Nov; 26(3):341-8. PubMed ID: 16722027
    [Abstract] [Full Text] [Related]

  • 18. Free-water transport in fast transport status: a comparison between CAPD peritonitis and long-term PD.
    Smit W, van den Berg N, Schouten N, Aikens E, Struijk DG, Krediet RT.
    Kidney Int; 2004 Jan; 65(1):298-303. PubMed ID: 14675063
    [Abstract] [Full Text] [Related]

  • 19. Intraperitoneal nitric oxide production in patients treated by continuous ambulatory peritonal dialysis.
    Davenport A, Fernando RL, Varghese Z.
    Blood Purif; 2004 Jan; 22(2):216-23. PubMed ID: 15044821
    [Abstract] [Full Text] [Related]

  • 20. Nitrate in stable CAPD patients and during peritonitis.
    Douma CE, de Waart DR, Zemel D, Imholz AL, Koomen GC, Struijk DG, Krediet RT.
    Adv Perit Dial; 1995 Jan; 11():36-40. PubMed ID: 8534733
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.